PPARG and metabolic dysfunction-associated steatotic liver disease: Previous studies have found that apigenin can regulate hepatocyte lipid metabolism and oxidative stress by adjusting PPARγ [31], Nrf2 [31], and XO/NLRP3 pathways [32], thereby attenuating HFD-induced NAFLD.